SEC Form 4 · accession 0001424422-16-000034
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Morlock
Director
Period of report
Aug 12, 2016
Accepted (ET)
Aug 16, 2016 · 7:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Aug 12, 2016 | A | 115,385 | $0.65 | A | 115,385 | D | |
| Common stockF1 | Aug 12, 2016 | A | 0 | $0.00 | A | 251,071 | I | By family trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03